Biochemical effect of intra-articular injections of high molecular weight hyaluronate in rheumatoid arthritis patients

Inflammation Research

Volumn 48, Issue 3, 1999, Pages 154-159

  Matsuno, H ^a   Yudoh, K ^a   Kondo, M ^b   Goto, M ^c   Kimura, T ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c Tokyo Metropolitan Ohtsuka Hospital   (Japan)

Author keywords

Hyaluronate; Intra articular injection; Rheumatoid arthritis

Indexed keywords

CHONDROITIN SULFATE; HYALURONIC ACID; SODIUM CHLORIDE;

ARTICLE; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HUMAN TISSUE; INTRAARTICULAR DRUG ADMINISTRATION; MOLECULAR WEIGHT; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; VISCOSITY;

ARTHRITIS, RHEUMATOID; CHONDROITIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; MOLECULAR WEIGHT; SYNOVIAL FLUID;

EID: 0033053817     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050439     Document Type: Article

References (46)

1. Schiavinato A, Lini E, Guidolin D, et al. Intraarticular sodium hyaluronate injections in the pond-nuki experimental model of osteoarthritis in dogs. Clin Orthop Rel Res 1989;341:286-99.
2. Manicourt DH, Pita JC. Progressive depletion of hyaluronic acid in early experimental osteoarthritis in dogs. Arthritis Rheum 1988;31:538-44.
3. Balazs EA, Denlinger JL. Sodium hyaluronate and joint function. JEVS 1985;5:217-28.
4. Phillips MW. Clinical trial comparison of intra-articular sodium hyaluronate products in the horse. JEVS 1989;9:39-40.
5. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Ann Rheum Dis 1996;55:424-31.
6. Pohl W, Bernac A, Greiling H, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cart 1988;1:233-41.
7. Rydell N, Endre AB. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop 1971;80:25-32.
8. Dixon ASJ, Jacoby RK, Beny H, Hamilton EBD. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 1988;11:205-13.
9. Leardini G, Mattara L, Franceschini M, Perbellini A. Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methylprednisolone acetate. Clin Exp Rheumatol 1991;9:375-81.
10. Namiki O, Toyoshima H, Morisaki N. Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. J Clin Pharm Ther Toxicol 1982;20:501-507.
11. Peyron JG, Balazs EA. Preliminary clinical assessment of Nahyaluronate injection into human arthritic joints. Pathol Biol 1974;22:731-6.
12. Punz L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S. The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 1989;7:247-50.
13. Goto M, Hosako Y, Katayama M, Yamada T. Biochemical analysis of rheumatoid synovial fluid after serial intra-articular injection of high molecular weight sodium hyaluronate. Int J Clin Pharm Res 1993;13:161-6.
14. Goldberg RL, Toole BP. Hyaluronate inhibition of cell proliferation. Arthritis Rheum 1987;30:769-78.
15. Darzynkiewicz Z, Balazs EA. Effect of connective tissue intercellular matrix on lymphocyte stimulation. I. Suppression of lymphocyte stimulation by hyaluronic acid. Exp Cell Res 1971;66:113-23.
16. Anastassiades T, Robertson W. Modulation of mitogen dependent lymphocyte stimulation by hyaluronic acid. J Rheumatol 1984;11:729-34.
17. Hough AJ, Sokoloff L. Pathology, Rheumatoid Arthritis. First edition. In Utsinger PD, Zvaifler NJ, Ehrlich GE, editors. Philadelphia: Lippincott, 1985:49-69.
18. Matsuno H, Matsushita I, Okada C, Suzuki M, Tsuji H, Ochiai H. Role of lymphocytes in collagen induced arthritis. J Rheumatol 1991;18:1344-9.
19. Shimazu A, Jikko A, Iwamoto M, Koike T, Yan W, Okada Y, et al. Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993;36:247-53.
20. Larsen NE, Lombard KM, Parent EG, Balazs E. Effects of hylan on cartilage and chondrocyte cultures. Orthop Res 1992;10:23-32.
21. Tobetto K, Nakai K, Akatsuka M, Yasui T, Ando T, Hiro S. Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res 1993;29:181-90.
22. Bensouyad A, Hollander AP, Dularay B, Bedwell AE, Cooper RA, Hutton CW, et al. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis. Ann Rheum Dis 1990;49:301-7.
23. Saxon T, Wollheim F, Petterson H, Heinegard D. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis? Br Med J 1987;295:1447-8.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Lansbury J. Quantitation of activity of rheumatoid arthritis: method for summation of systemic indices of rheumatoid activity. Am J Med Sci 1953;232:300-17.
26. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
27. Larsen A, Dahl K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagnosis 1977;18:481-91.
28. Woolock JB. The capsule of streptococcus equi. J Gen Microbiol 1974;85:372-5.
29. West DC, Kumar S. Hyaluronan and angiogenesis. The biology of hyaluronan. Ciba Foundation Symposium 143. Chichester: John Wiley and Sons, 1989:187-207.
30. Yoshioka M, Shimizu C, Harwood FL, Coutts RD, Amiel D. The effects of hyaluronan during the development of osteoarthritis. Osteoarthritis Cart 1997;5:251-60.
31. Tanaka S, Yamamoto M, Komatsubara Y, et al. Clinical study of high molecular hyaluronic acid (NRD 101) on rheumatoid arthritis. Clin Rheumatol 1994;5:279-303.
32. Strominger JL, Park JT, Thompson RE. Composition of the cell wall of staphylococcus aureus: Its relation to the mechanism of action of penicillin. J Biol Chem 1959;234:3263-8.
33. Laurent TC, Ryan M, Pietruszkiewicz A. Fractionation of hyaluronic acid from the bovine vritreous body. Biochem Biophys Acta 1960;42:476-85.
34. Lowry OH, Rosebrough NJ, Farr AL, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
35. Shinmei M, Miyauchi S, Machida S, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-slufate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
36. Lockshin MD. Corticosteroids, Rheumatoid arthritis, First edition. In: Utsinger PD, Zvaifler NJ, Ehrlich GE, editors. Philadelphia: Lippincott, 1985.
37. Akatsuka M, Yamamoto Y, Tobetto K, Yasui T, Ando K. Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leucocytes. J Pharm Pharmacol 1993;45:110-4.
38. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980;40:435-46.
39. Tobetto K, Yasui T, Ando T, Hayaishi M, Motohashi N, Shinogi M, et al. Inhibitory effects of hyaluronan on [14C] arrachinodic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol 1992;60:79-84.
40. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injection of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994;53:529-34.
41. Puttick MPE, Wade JP, Chalmers A, Connell DG, Rango KK. Acute local reaction after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1995;22:1311-4.
42. Matsuno H, Sakai K, Tsuji H, Kondoh M. Effects of highmolecular weight hyaluronic acid in rheumatoid arthritis patients [in Japanese]. Chubu Rheum Assoc 1995;26:40-4.
43. Hasselbacher P. Synovial fluid analysis, Rheumatoid Arthritis. First edition. In: Utsinger PD, Zvaifler NJ, Ehrich GE, editors. Philadelphia: Lippincott, 1985:193-208.
44. Matsuno H, Nezuka T, Tsuji H, Maeda H. Changes in properties of synovial fluid in RA patients treated with intra-articular steroid therapy [in Japanese]. J Chubu Rheum Assoc 1996;27:20-1.
45. Balazs EA, Watson D, Duff IF, Raseman S. Hyaluronic acid in synovial fluid. I: Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357-76.
46. Dahl LB, Dahl MB, Laurent AE, Granath AK. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.